Resources
Search all resources on this page or select a tab to see publications, videos, audio, collections of related resources and more.
Budget 2022–23: Addressing the impact of alcohol and other drugs
A Budget 2022–23 fact sheet.
Part of a collection: Budget 2022–23: Prioritising mental health, preventive health and sportNational Ice Action Strategy 2015
This strategy aims to reduce the use and harmful effects of ice in Australia.
Part of a collection: National Drug StrategyEvaluation of the Pharmaceutical Benefits Scheme subsidised take home naloxone pilot
This report presents the final evaluation findings, covering the pilot in NSW, SA and WA from commencement on 1 December 2019 up until 30 June 2021.
ANACAD summary of activities 2020–21
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2020 to 30 June 2021.
National Alcohol and Other Drug Workforce Development Strategy 2015–2018
This strategy aims to improve the skills of the alcohol and other drug (AOD) workforce and prepare them for the future.
Part of a collection: National Drug StrategyANACAD summary of activities 2019–20
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2019 to 30 June 2020.
National Drug Strategy
The National Drug Strategy aims to reduce and prevent harm caused by drugs. Six sub-strategies focus on specific issues such as alcohol, ice, tobacco, and workforce development.
AODconnect app
AODconnect is a national directory of alcohol and other drug treatment services for Aboriginal and Torres Strait Islander peoples. The app is available on iOS and Android devices.
Evaluation of the National Ice Action Strategy (NIAS)
This document is a response to the findings of the National Ice taskforce in 2015. This report provides a comprehensive assessment of the NIAS.
Part of a collection: National Drug StrategyOpioid Prescribing Practices Project - Key Outcomes
This report outlines the findings of a randomised controlled trial (RCT) conducted by the Department of Health. The RCT explored whether a letter designed with behavioural insights principles would help GPs reflect on their opioid prescribing.
Real Time Prescription Monitoring public summary of the Privacy Impact Assessment
The Real Time Prescription Monitoring (RTPM) Privacy Impact Assessment (PIA) was conducted to ensure the Nation Data Exchange (NDE) system contained the appropriate obligations and protections in relation to the collection and storage of individual personal information.
Certification statement – Safe and effective use of prescription opioids campaign
This certificate of compliance, signed by Secretary Brendan Murphy, certifies that the safe and effective prescription opioids campaign complies with relevant guidelines and policies.
Part of a collection: Certification statements for advertising campaignsThis webinar hosted by Prof. Michael Kidd AM focuses on the impact of the revised Opioid prescribing changes from 1 June 2020. The expert panel will provide information and answer participants’ questions.
National Framework for Alcohol, Tobacco and Other Drug Treatment 2019–29
This framework’s aim is that all Australians seeking alcohol and other drug treatment can access high quality treatment appropriate to their needs, when and where they need it. It includes principles for effective treatment, monitoring and evaluation.
Trends in substance use among Australian secondary school students 1996–2017
This report presents trends data of the Australian Secondary Students' Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs, 1996–2017.
Part of a collection: Australian secondary school students alcohol and drug (ASSAD) survey 2017Secondary school students’ use of tobacco, alcohol and other drugs in 2017
This report presents the results of the Australian Secondary Students’ Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs.
Part of a collection: Australian secondary school students alcohol and drug (ASSAD) survey 2017National Drug Strategy 2018 Annual Report
This Annual Report is consistent with the National Drug Strategy 2017–2026.
Part of a collection: National Drug StrategyNew Horizons: review of alcohol and other drug treatment services
This 2014 report describes the alcohol and other drug (AOD) treatment system and funding processes in Australia. It provides options for future funding that respond to the needs of individuals, families and communities.
ANACAD summary of activities 2018–19
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2018 to 30 June 2019.
National Quality Framework for Drug and Alcohol Treatment Services
This framework sets a nationally consistent quality benchmark for providers of drug and alcohol treatment services. It includes strong clinical governance requirements and a list of accreditation standards that drug and alcohol specialist treatment service providers must meet.
Ministerial Drug and Alcohol Forum (MDAF) communiques
These communiques are a summary of the items discussed at MDAF meetings.
Ministerial Drug and Alcohol Forum (MDAF) Communiqué 28 November 2019
A summary of the major items discussed at the fifth MDAF meeting.
Part of a collection: Ministerial Drug and Alcohol Forum (MDAF) communiquesCracks in the ice app
The Cracks in the ice app provides trusted, evidence-based, and up-to-date information and resources about crystal methamphetamine (ice) for the Australian community.
Australian secondary school students alcohol and drug (ASSAD) survey 2017
Every 3 years 20,000 to 30,000 secondary students aged between 12 and 17 take part in a national survey of adolescent substance use in Australia. These reports present the findings from the 2017 surveys.
ANACAD summary of activities 2017–18
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2017 to 30 June 2018.